Completed
Approximately 4 million pregnant people in the United States give birth annually, and 70 percent of these individuals take at least one prescription medication during their pregnancy. Yet, pregnant and lactating persons are often excluded from clinical trials, and often have to make treatment decisions without an adequate understanding of the benefits and risks to themselves and their developing fetus or newborn baby. An ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will develop a framework for addressing medicolegal and liability issues when planning or conducting research specific to pregnant and lactating persons.
Featured publication
Consensus
·2024
Congress called on the National Academies to convene a committee to examine the real and perceived risks of liability arising from research conducted with pregnant and lactating women. The resulting report, Clinical Research with Pregnant and Lactating Populations: Overcoming Real and Perceived Liab...
View details
Publications
Policy Brief
Policy Brief for the Role of the National Institutes of Health
Policy Brief
Policy Brief for the Role of the Food and Drug Administration
Policy Brief
Policy Brief for the Role of the U.S. Congress
Policy Brief
Policy Brief for the Role of the U.S. Department of Health and Human Services
Policy Brief
Highlights
Consensus Study Highlights
Highlights
Advancing Clinical Research with Pregnant and Lactating Populations: Overcoming Real and Perceived Liability Risks
Highlights